İçeriğe geç

Neonatoloji

Hiperbilirubinemi Tedavisi

Fototerapi

Randomised controlled trial of single phototherapy with reflecting curtains versus double phototherapy in term newborns with hyperbilirubinaemia. (yeni pencere açar)

Abd Hamid IJ, M Iyen MI, Ibrahim NR, Abd Majid N, Ramli N, Van Rostenberghe H.

Kaynak‎: J Paediatr Child Health 2013;49(5):375-9.

İndeks‎: PubMed 23573836

DOI‎: 10.1111/jpc.12192

https://www.ncbi.nlm.nih.gov/pubmed/23573836 (yeni pencere açar)

Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. (yeni pencere açar)

Bhutani VK; Committee on Fetus and Newborn; American Academy of Pediatrics.

Kaynak‎: Pediatrics 2011;128(4):e1046-52.

İndeks‎: PubMed 21949150

DOI‎: 10.1542/peds.2011-1494

https://www.ncbi.nlm.nih.gov/pubmed/21949150 (yeni pencere açar)

High-intensity phototherapy for the treatment of severe nonhaemolytic neonatal hyperbilirubinemia. (yeni pencere açar)

de Carvalho M, Mochdece CC, Sá CA, Moreira ME.

Kaynak‎: Acta Paediatr 2011;100(4):620-3.

İndeks‎: PubMed 21251060

DOI‎: 10.1111/j.1651-2227.2011.02170.x

https://www.ncbi.nlm.nih.gov/pubmed/21251060 (yeni pencere açar)

Efficacy of phototherapy for neonatal jaundice is increased by the use of low-cost white reflecting curtains. (yeni pencere açar)

Djokomuljanto S, Quah BS, Surini Y, Noraida R, Ismail NZ, Hansen TW, Van Rostenberghe H.

Kaynak‎: Arch Dis Child Fetal Neonatal Ed 2006;91(6):F439-42.

İndeks‎: PubMed 16877479

DOI‎: 10.1136/adc.2006.095687

https://www.ncbi.nlm.nih.gov/pubmed/16877479 (yeni pencere açar)

Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia. (yeni pencere açar)

Gholitabar M, McGuire H, Rennie J, Manning D, Lai R.

Kaynak‎: Cochrane Database Syst Rev 2012;(12):CD009017.

İndeks‎: PubMed 23235669

DOI‎: 10.1002/14651858.CD009017.pub2

https://www.ncbi.nlm.nih.gov/pubmed/23235669 (yeni pencere açar)

Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. (yeni pencere açar)

Kumar P, Chawla D, Deorari A.

Kaynak‎: Cochrane Database Syst Rev 2011;(12):CD007969.

İndeks‎: PubMed 22161417

DOI‎: 10.1002/14651858.CD007969.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22161417 (yeni pencere açar)

Efficacy of phototherapy devices and outcomes among extremely low birth weight infants: multi-center observational study. (yeni pencere açar)

Morris BH, Tyson JE, Stevenson DK, Oh W, Phelps DL, O'Shea TM, McDavid GE, Van Meurs KP, Vohr BR, Grisby C, Yao Q, Kandefer S, Wallace D, Higgins RD.

Kaynak‎: J Perinatol 2013;33(2):126-33.

İndeks‎: PubMed 22499082

DOI‎: 10.1038/jp.2012.39

https://www.ncbi.nlm.nih.gov/pubmed/22499082 (yeni pencere açar)

Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants. (yeni pencere açar)

Okwundu CI, Okoromah CA, Shah PS.

Kaynak‎: Cochrane Database Syst Rev 2012;(1):CD007966.

İndeks‎: PubMed 22258977

DOI‎: 10.1002/14651858.CD007966.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22258977 (yeni pencere açar)

The effect of clofibrate with phototherapy in late pre-term newborns with non-hemolytic jaundice. (yeni pencere açar)

Sakha SH, Gharehbaghi MM, Rahbani ME.

Kaynak‎: Indian J Med Sci 2009;63(5):174-9.

İndeks‎: PubMed 19584487

DOI‎: 10.4103/0019-5359.53162

https://www.ncbi.nlm.nih.gov/pubmed/19584487 (yeni pencere açar)

A randomized trial of phototherapy with filtered sunlight in African neonates. (yeni pencere açar)

Slusher TM, Olusanya BO, Vreman HJ, Brearley AM, Vaucher YE, Lund TC, Wong RJ, Emokpae AA, Stevenson DK.

Kaynak‎: N Engl J Med 2015;373(12):1115-24.

İndeks‎: PubMed 26376136

DOI‎: 10.1056/NEJMoa1501074

https://www.ncbi.nlm.nih.gov/pubmed/26376136 (yeni pencere açar)

Dose-response relationship of phototherapy for hyperbilirubinemia. (yeni pencere açar)

Vandborg PK, Hansen BM, Greisen G, Ebbesen F.

Kaynak‎: Pediatrics 2012;130(2):e352-7.

İndeks‎: PubMed 22802603

DOI‎: 10.1542/peds.2011-3235

https://www.ncbi.nlm.nih.gov/pubmed/22802603 (yeni pencere açar)

İntravenöz İmmünoglobülin Tedavisi

High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. (yeni pencere açar)

Alpay F, Sarici SU, Okutan V, Erdem G, Ozcan O, Gökçay E.

Kaynak‎: Acta Paediatr 1999;88(2):216-9.

İndeks‎: PubMed 10102158

https://www.ncbi.nlm.nih.gov/pubmed/10102158 (yeni pencere açar)

High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. (yeni pencere açar)

Dağoğlu T, Ovali F, Samanci N, Bengisu E.

Kaynak‎: J Int Med Res 1995;23(4):264-71.

İndeks‎: PubMed 7589769

DOI‎: 10.1177/030006059502300406

https://www.ncbi.nlm.nih.gov/pubmed/7589769 (yeni pencere açar)

Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and ABO incompatibility. (yeni pencere açar)

Huizing K, Røislien J, Hansen T.

Kaynak‎: Acta Paediatr 2008;97(10):1362-5.

İndeks‎: PubMed 18616629

DOI‎: 10.1111/j.1651-2227.2008.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/18616629 (yeni pencere açar)

Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. (yeni pencere açar)

Miqdad AM, Abdelbasit OB, Shaheed MM, Seidahmed MZ, Abomelha AM, Arcala OP.

Kaynak‎: J Matern Fetal Neonatal Med 2004;16(3):163-6.

İndeks‎: PubMed 15590442

DOI‎: 10.1080/14767050400009873

https://www.ncbi.nlm.nih.gov/pubmed/15590442 (yeni pencere açar)

Tin Mezoporfirin

Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia. (yeni pencere açar)

Bhutani VK, Poland R, Meloy LD, Hegyi T, Fanaroff AA, Maisels MJ.

Kaynak‎: J Perinatol 2016;36(7):533-9.

İndeks‎: PubMed 26938918

DOI‎: 10.1038/jp.2016.22

https://www.ncbi.nlm.nih.gov/pubmed/26938918 (yeni pencere açar)

Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant. (yeni pencere açar)

Reddy P, Najundaswamy S, Mehta R, Petrova A, Hegyi T.

Kaynak‎: J Perinatol 2003;23(6):507-8.

İndeks‎: PubMed 13679941

DOI‎: 10.1038/sj.jp.7210943

https://www.ncbi.nlm.nih.gov/pubmed/13679941 (yeni pencere açar)

Diğer İlaçlar

Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy. (yeni pencere açar)

Honar N, Ghashghaei Saadi E, Saki F, Pishva N, Shakibazad N, Hosseini Teshnizi S.

Kaynak‎: J Pediatr Gastroenterol Nutr 2016;62(1):97-100.

İndeks‎: PubMed 26020375

DOI‎: 10.1097/MPG.0000000000000874

https://www.ncbi.nlm.nih.gov/pubmed/26020375 (yeni pencere açar)

Hyperbilirubinemia in the newborn infant > or =35 weeks' gestation: an update with clarifications. (yeni pencere açar)

Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF.

Kaynak‎: Pediatrics 2009;124(4):1193-8.

İndeks‎: PubMed 19786452

DOI‎: 10.1542/peds.2009-0329

https://www.ncbi.nlm.nih.gov/pubmed/19786452 (yeni pencere açar)

A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. (yeni pencere açar)

Mehta S, Kumar P, Narang A.

Kaynak‎: J Pediatr 2005;147(6):781-5.

İndeks‎: PubMed 16356431

DOI‎: 10.1016/j.jpeds.2005.07.026

https://www.ncbi.nlm.nih.gov/pubmed/16356431 (yeni pencere açar)

Treatment of clofibrate in jaundiced low birth weight neonates. [English, Turkish abstract] (yeni pencere açar)

Mohammadzadeh A, Farhat AS, Amiri R, Esmaely H, Bagheri S.

Kaynak‎: UHOD-Uluslar Hematol Onkol De (Int J Hematol Oncol) 2009;19(2):100-5.

İndeks‎: EMBASE 2009472903

http://www.uhod.org/summary_en.php3?id=359 (yeni pencere açar)

Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial). (yeni pencere açar)

Zahedpasha Y, Ahmadpour-Kacho M, Hajiahmadi M, Naderi S, Kamali AA.

Kaynak‎: Southeast Asian J Trop Med Public Health 2008;39(3):557-61.

İndeks‎: PubMed 18564698

https://www.ncbi.nlm.nih.gov/pubmed/18564698 (yeni pencere açar)